Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.

from Dementia Big http://ift.tt/1Tlbfvn
via Stopping Dementia

from WordPress http://ift.tt/1SCryaW
via alcoholic dementia
http://ift.tt/1X0M7Ql